Tiziana Life Sciences Ltd. Common Shares (TLSA) is a publicly traded Healthcare sector company. As of November 2, 2026, TLSA trades at $0.70 with a market cap of $101.81M and a P/E ratio of 0.00. TLSA moved -13.07% today. Year to date, TLSA is -50.00%; over the trailing twelve months it is -56.52%. Its 52-week range spans $0.73 to $2.60. Analyst consensus is buy with an average price target of $7.00. Rallies surfaces TLSA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for TLSA, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $0.70 |
| Market Cap | $101.81M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $2.60 |
| 52-Week Low | $0.73 |
| Volume | 93.81K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
1 analysts cover TLSA: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $7.00.